Investing in Innovation Africa (i3), a pan-African initiative to support African healthtech startups to commercialise and scale their offerings has decided to make a pivotal change to its 3rd cohort ...

The sale netted about $300 million for Walgreens and shrinks the company’s stake in Cencora to approximately 6%, down from 10 ...

Walgreens said it plans to use the proceeds to pay down debt and invest in other corporate functions, while stressing that the sale has no impact on its partnership with Cencora. Walgreens and ...

Despite acknowledgements of the tense political climate, a group of trailblazers centered hope in conversations with one ...

Over the past year, many Cencora, Inc. (NYSE:COR) insiders sold a significant stake in the company which may have piqued investors' interest. Knowing whether insiders are buying is usually more ...

Support of NBA All-Star 2025 will begin a shared commitment to exploring future opportunities and encouraging acts of service ...

President of the Southern Center for Broadening Participation in STEM, Dr. Calvin Briggs works alongside several ...

Cencora, Inc. (NYSE:COR – Get Free Report) has received an average recommendation of “Moderate Buy” from the eleven ratings firms that are covering the firm, Marketbeat Ratings reports.

Cencora, Inc. (NYSE:COR – Free Report) – Equities researchers at Leerink Partnrs lifted their Q3 2025 earnings estimates for Cencora in a research report issued on Wednesday, February 5th.

Over the past year, many Cencora, Inc. (NYSE:COR) insiders sold a significant stake in the company which may have piqued investors' interest. Knowing whether insiders are buying is usually more ...